Yotta vs Abridge

Side-by-side comparison of AI visibility scores, market position, and capabilities

Abridge leads in AI visibility (41 vs 30)
Yotta logo

Yotta

EmergingFinance

General

NYC YC W20 prize-linked savings/sweepstakes fintech at 700K+ members; severely impacted by Synapse bankruptcy May 2024 leaving 85K customers unable to access $112M in deposits; $17.9M total ($13.2M Base10 Series A 2021).

AI VisibilityBeta
Overall Score
D30
Category Rank
#1033 of 1158
AI Consensus
77%
Trend
up
Per Platform
ChatGPT
30
Perplexity
26
Gemini
25

About

Yotta is a New York-based fintech company — backed by Y Combinator (W20) with $17.9-21.2 million in total funding including a $13.2 million Series A in January 2021 led by Base10 Partners with Y Combinator, Core Innovation Capital, and Slow Ventures — offering sweepstakes games with a member base of 700,000+ people, after previously operating prize-linked savings accounts before being severely impacted by the Synapse Financial Technologies bankruptcy in May 2024. When Synapse (Yotta's banking-as-a-service middleware partner) failed, approximately 85,000 Yotta customers with $112 million in deposits lost account access — and as of November 2024, 13,725 depositors were offered only $11.8 million of $64.9 million in claimed deposits, illustrating the systemic risk that BaaS middleware dependency creates for fintech customer funds.

Full profile
Abridge logo

Abridge

EmergingHealthcare

General

Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.

AI VisibilityBeta
Overall Score
C41
Category Rank
#777 of 1158
AI Consensus
50%
Trend
up
Per Platform
ChatGPT
35
Perplexity
49
Gemini
33

About

Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.

Full profile

AI Visibility Head-to-Head

30
Overall Score
41
#1033
Category Rank
#777
77
AI Consensus
50
up
Trend
up
30
ChatGPT
35
26
Perplexity
49
25
Gemini
33
30
Claude
51
21
Grok
38

Key Details

Category
General
General
Tier
Emerging
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.